Professor of Oncology, Johns Hopkins University School of Medicine
Oncology
Dr. Antonio C. Wolff, MD
|
|
Give Review
Antonio Wolff practices Oncology. He has 7 awards "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area", "Top Doctors:Washington-Baltimore", "Fellow (FASCO)" and "Fellow (FACP)". Antonio Wolff is a published MD as well. He has 37 publications published. The latest was: Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast C... Antonio C. Wolff, MD accepts Medicare.
Publications
- Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary St...
- Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast C...
- Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer.
- Long term side effects of adjuvant chemotherapy in patients with early breast Cancer.
- Reply to E.A. Rakha et al.
- Significance of Circulating Tumor Cells in metastatic triple negative breast Cancer patients within a randomized, phase II trial: TBCRC 019.
- Comorbid condition care quality in Cancer survivors: role of primary care and specialty providers and care coordination.
- TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative Systemic therapy in human epidermal growth factor receptor 2-negative primary operab...
- Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast Cancer.
- Risk of Marrow Neoplasms After Adjuvant Breast Cancer Therapy: The National Comprehensive Cancer Network Experience.
- A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF-Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer.
- TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast Cancer brain metastases.
- Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast Cancer.
- It's who you know: patient-sharing, quality, and costs of Cancer survivorship care.
- Treatment of HER2-positive breast Cancer.
- Recommendations for human epidermal growth factor receptor 2 testing in breast Cancer: american society of clinical oncology/college of american pathologists clinical ...
- A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung Cancers.
- Feasibility and value of PatientViewpoint: a web System for patient-reported outcomes assessment in clinical practice.
- Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast Cancer.
- Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update.
- Omics as useful tools in clinical practice: are we there yet?
- Quality of care for comorbid conditions during the transition to survivorship: differences between Cancer survivors and nonCancer controls.
- Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or meta...
- Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast Cancer.
- Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast Cancer.
- Comparing care for breast Cancer survivors to non-Cancer controls: a five-year longitudinal study.
- Prevention, screening, and surveillance care for breast Cancer survivors compared with controls: changes from 1998 to 2002.
- Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-Analysis.
- Use of SERMs for the adjuvant therapy of early-stage breast Cancer.
- Systemic therapy.
- Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast Cancer.
- New data on adjuvant therapy for breast Cancer.
- Primary systemic therapy in operable breast Cancer.
- Adjuvant Systemic management of early stage carcinoma of the breast.
- Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast Cancer: an Eastern Cooperative Oncology Group Study.
- Do breast Cancer cell lines provide a relevant model of the patient tumor methylome?
Schools
Federal University of Rio De Janeiro Faculty of Medicine Center of Health Science
Good Samaritan Hospital
Mt Sinai Med Center
Johns Hopkins
Washington University
Procedures Preformed
- Thoracentesis
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bladder Cancer
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
- Top Doctors:Washington-Baltimore
- Fellow (FASCO)
- Fellow (FACP)
Education
-
Johns Hopkins University -
Washington University - Barnes-Jewish Hospital -
Faculdade de Medicina da Universidade Federal do Rio de Janeiro
Hospital
-
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Drug Facts
| NPI NUMBER | 1861420291 | |
| NPPES Provider LastName | WOLFF | |
| NPPES Provider FirstName | ANTONIO | |
| NPPES Provider ZIPCode | 210934515 | |
| NPPES Provider State | MD | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 101.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861420291 |
| Last Name Of The Provider | WOLFF |
| First Name Of The Provider | ANTONIO |
| View All |
Similar Doctors
|
|
Dr. Eric J. Seifter, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ross C. Donehower, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet Cooper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Downs, MD |
|
|
Dr. William H. Sharfman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. Huslig, MD
This Doctor is OpenDoctor Recommended.
|